Home/Filings/4/0001179110-14-017218
4//SEC Filing

HOSPIRA INC 4

Accession 0001179110-14-017218

CIK 0001274057operating

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:50 PM ET

Size

8.7 KB

Accession

0001179110-14-017218

Insider Transaction Report

Form 4
Period: 2014-11-25
Yoskowitz Marc J
SVP, Strategy & Corporate Dev
Transactions
  • Exercise/Conversion

    Common Stock

    2014-11-25$37.36/sh+11,523$430,49943,146 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2014-11-25+11,52334,570 total
    Exercise: $37.36Exp: 2020-06-28Common Stock (11,523 underlying)
  • Sale

    Common Stock

    2014-11-25$59.93/sh11,523$690,60831,623 total
Footnotes (3)
  • [F1]Exercise of derivative security exempted pursuant to Rule 16b-3.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $59.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
  • [F3]The stock options, granted on June 28, 2013, vest in four equal annual installments on June 28, 2014, 2015, 2016, and 2017. The exercise price of $37.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on June 28, 2020.

Issuer

HOSPIRA INC

CIK 0001274057

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001274057

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:50 PM ET
Size
8.7 KB